These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24010910)

  • 21. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
    Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
    J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of positron emission tomography/computed tomography in breast cancer.
    Bourgeois AC; Warren LA; Chang TT; Embry S; Hudson K; Bradley YC
    Radiol Clin North Am; 2013 Sep; 51(5):781-98. PubMed ID: 24010906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Gad D, Hoiland-Carlesen PF, Bartram P, et al.: staging patients with cutaneous malignant melanoma by same day lymphoscintigraphy and sentinel lymph node biopsy: a single-institutional experience with emphasis on recurrence.
    van Rijk MC; Nieweg OE; Kroon BB
    J Surg Oncol; 2006 Aug; 94(2):170-1; author reply 172. PubMed ID: 16847827
    [No Abstract]   [Full Text] [Related]  

  • 24. Positron emission tomography for staging and management of malignant melanoma.
    Prichard RS; Hill AD; Skehan SJ; O'Higgins NJ
    Br J Surg; 2002 Apr; 89(4):389-96. PubMed ID: 11952577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of nuclear medicine in staging and management in a case of Merkel cell carcinoma.
    Ochoa-Figueroa MA; Uña-Gorospe J; Allende-Riera A; Muñoz-Iglesias J; Cárdenas-Negro C; González-Delgado B
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):354-6. PubMed ID: 23169391
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
    Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
    J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Navigation-assisted localisation and resection of subclinical metastatic malignant melanoma of unknown primary based on 18-fluorodeoxyglcose positron emission tomography computed tomography fusion imaging.
    Ghazali N; Collyer JC; Tighe J
    Int J Oral Maxillofac Surg; 2012 Jan; 41(1):5-8. PubMed ID: 22024137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Preoperative PET/CT Staging in Sentinel Lymph Node-Positive Melanoma.
    Scheier BY; Lao CD; Kidwell KM; Redman BG
    JAMA Oncol; 2016 Jan; 2(1):136-7. PubMed ID: 26401901
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications.
    Wagner JD
    Ann Surg Oncol; 2006 Apr; 13(4):444-6. PubMed ID: 16491336
    [No Abstract]   [Full Text] [Related]  

  • 30. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
    Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
    Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
    Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of positron emission tomography/computed tomography in bone malignancies.
    Peller PJ
    Radiol Clin North Am; 2013 Sep; 51(5):845-64. PubMed ID: 24010909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of positron emission tomography and computed tomography in clinical staging of cutaneous malignant melanoma.
    Yılmaz H; Orhan E; Şahin E; Olguner AA; Arpacı E
    Dermatol Ther; 2020 May; 33(3):e13304. PubMed ID: 32160381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node biopsy.
    Lee KK; Vetto JT; Mehrany K; Swanson NA
    Clin Dermatol; 2004; 22(3):234-9. PubMed ID: 15262310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
    Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
    Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
    Mijnhout GS; Pijpers R; Hoekstra OS; Teule GJ; Borgstein PJ; Meijer S
    Cancer; 1999 Mar; 85(5):1199-201. PubMed ID: 10091807
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of hybrid SPECT/CT for lymphatic mapping in patients with melanoma.
    Fairbairn N; Munson C; Khan ZA; Butterworth M
    J Plast Reconstr Aesthet Surg; 2013 Sep; 66(9):1248-55. PubMed ID: 23697997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review.
    Schröer-Günther MA; Wolff RF; Westwood ME; Scheibler FJ; Schürmann C; Baumert BG; Sauerland S; Kleijnen J
    Syst Rev; 2012 Dec; 1():62. PubMed ID: 23237499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
    Hafner J
    Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
    [No Abstract]   [Full Text] [Related]  

  • 40. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.